Additional file 2: Figure S2. of Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study

Comparison of serum IL-5, CXCL9, and VGEF-A levels between long survivors and non-long survivors in the 2 cohorts. (PDF 117 kb)